sofosbuvir

Cipla Launches Hepcvir-L For HepC Genotype 1 Patients

Hepcvir-L will be provided to patients in India at the fraction of the cost of branded Ledipasvir-Sofosbuvir under a licensing agreement with Gilead Sciences Inc.

Generic Hepatitis Drug Launched In India As Hepcvir

Generics manufacturer Cipla has been granted the license to produce Sofosbuvir in India under the brand name Hepcvir.